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BACKGROUND: Opioid overdose deaths occur in civilian
and military populations and are the leading cause of
accidental death in the USA.
OBJECTIVE: To determine whether ECHO Pain
telementoring regarding best practices in pain management and safe opioid prescribing yielded significant declines in opioid prescribing.
DESIGN: A 4-year observational cohort study at military
medical treatment facilities worldwide.
PARTICIPANTS: Patients included 54.6% females and
46.4% males whose primary care clinicians (PCCs) opted
to participate in ECHO Pain; the comparison group included 39.9% females and 60.1% males whose PCCs
opted not to participate in ECHO Pain.
INTERVENTION: PCCs attended 2-h weekly Chronic Pain
and Opioid Management TeleECHO Clinic (ECHO Pain),
which included pain and addiction didactics, case-based
learning, and evidence-based recommendations. ECHO
Pain sessions were offered 46 weeks per year. Attendance
ranged from 1 to 3 sessions (47.7%), 4–19 (32.1%, or > 20
(20.2%).
MAIN MEASURES: This study assessed whether clinician
participation in Army and Navy Chronic Pain and Opioid
Management TeleECHO Clinic (ECHO Pain) resulted in
decreased prescription rates of opioid analgesics and coprescribing of opioids and benzodiazepines. Measures included opioid prescriptions, morphine milligram equivalents (MME), and days of opioid and benzodiazepine coprescribing per patient per year.
KEY RESULTS: PCCs participating in ECHO Pain had
greater percent declines than the comparison group in
(a) annual opioid prescriptions per patient (− 23% vs. −
9%, P < 0.001), (b) average MME prescribed per patient/
year (−28% vs. −7%, p < .02), (c) days of co-prescribed
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opioid and benzodiazepine per opioid user per year
(−53% vs. −1%, p < .001), and (d) the number of opioid
users (−20.2% vs. −8%, p < .001). Propensity scoring
transformation–adjusted results were consistent with
the opioid prescribing and MME results.
CONCLUSIONS: Patients treated by PCCs who opted to
participate in ECHO Pain had greater declines in opioidrelated prescriptions than patients whose PCCs opted not
to participate.
KEY WORDS: clinician education; project ECHO; telementoring; opioids;
opioid overdose deaths; benzodiazepines.
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INTRODUCTION

An estimated 100 million Americans suffer from chronic
pain.1 In the USA, prescriptions for opioid analgesics quadrupled between 1999 and 2012.2 Prescribing behaviors associated with increased overdose risk include co-prescribing benzodiazepines and opioids and exceeding a daily dose of 50
morphine milligram equivalents (MME).3, 4 Approximately
175 people die everyday from drug-related deaths.5 Drug
overdose deaths surpass injury deaths caused by motor vehicle
accidents and firearms.6 The public health epidemics of chronic pain and drug overdose affect both civilian and military
populations.7–10
Chronic pain, opioid use disorder (OUD), and posttraumatic stress disorder (PTSD) frequently occur together.
Preventing these conditions is a high priority for the Department of Defense (DoD).10–15 Pain is a leading reason
patients seek medical care and primary care clinicians
(PCCs) are often the first points of contact.16, 17 Pain
management and safe opioid prescribing education for
civilian pre-licensure students and PCCs is not universally
required, but is required for MHS clinicians.18–21
387
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Opioid misuse is a problem for both military and civilian
populations.4 When opioids are prescribed to patients with
PTSD and other mental health diagnoses, this may increase
their risk for adverse events.11, 22, 23 In 2009, the DoD
recognized that the military needed an optimal pain management plan and prepared a Pain Management Task Force
(PMTF) Report recommending an evidence-based approach to manage chronic pain across the Military Health
System (MHS).24 Among several training platforms available for pain education, the U.S. Army chose the University of New Mexico Health Sciences Center (UNMHSC)
Project ECHO (Extension for Community Healthcare Outcomes) model of Chronic Pain training for its rapid diffusion of pain management strategies.25
This observational cohort study assessed whether PCC
participation in telementoring through the Chronic Pain
and Opioid Management TeleECHO Clinic (ECHO Pain)
improved pain management and safe opioid prescribing
skills.

METHODS

The ECHO Model
Project ECHO is a lifelong learning and guided practice model
of medical education and mentoring that uses a hub-and-spoke
design to create knowledge networks. Expert teams at the hub
use multi-point videoconferencing to conduct virtual learning
sessions. Spoke attendees include physicians, advanced practice clinicians, and care teams. TeleECHO sessions run for 2 h
weekly (96 total hours annually). Each session consists of a
short, evidence-based didactic followed by case discussions
intended to reduce variations in care.
Benefits for participating in ECHO Pain include no-cost
continuing medical education (CME) credits and increased
diagnostic, treatment, and referral skills related to multimodal pain management and OUD.26 Clinicians learn prescribing behaviors that reduce opioid overdose risks including judicious use of opioids, identification of patients
at risk of OUD, and risks of co-prescribing.27–29 Participating PCCs learn to provide specialty care which would
otherwise be difficult to obtain for patients in their own
communities.30, 31

Army and Navy ECHO Pain Intervention
Between 2012 and 2014, military medical treatment facilities
(MTFs) were strategically chosen to serve as hub sites based
on geographical location (time zone) and availability of specialty clinicians to serve as facilitators. Integrative and interdisciplinary pain teams were fully staffed at five U.S. Army
and two U.S. Navy hub sites. The 47 remote Army and 33
remote Navy spoke locations were chosen based on PCC
interest and volume of chronic pain patients. Project ECHO
provided on-site and virtual trainings to both the hub and

JGIM

spoke clinicians regarding facilitation, case presentation skills,
and the basics of pain management. See Fig. 1.
Study Design. This is an observational cohort study
comparing ECHO Pain participating PCCS with nonECHO Pain participating PCCs. Clinics were separated
into two primary groups: (1) 99 clinics whose PCCs
voluntarily participated in ECHO Pain at least once per
year and had data both before and after ECHO intervention and (2) 1283 comparison clinics that whose PCCs did
not participate in ECHO Pain. Prescription counts for
adult patients enrolled with Army and Navy PCC teams
for fiscal years 2013 to 2016 (i.e., October through September) were supplied, de-identified, and aggregated from
the Military Health System Data Repository (MDR). The
MDR patient data was stratified by combinations of the
covariables: fiscal year, age, sex, and beneficiary category
and aggregated in these patient strata (combinations) for
each clinic. Our study excluded patients under 18 years.
Beneficiary categories included active duty military personnel, dependents of active duty personnel, members of
the National Guard or Reserve, and military retirees.
ECHO Pain data was additionally stratified for pre/post
ECHO intervention. PCCs for ECHO Pain were either
active duty or civilian clinicians working at Army or Navy
MTFs (see Fig. 2).

Primary and Secondary Outcomes
The primary outcome of this study was to assess whether
voluntary PCC participation in ECHO Pain resulted in
decreased prescriptions of opioids for enrolled patients.
Secondary outcome measures included evaluation of
MME dose and co-prescribing of opioids and benzodiazepines. Both primary and secondary outcome measures were
developed prior to the launch of Army and Navy ECHO
Pain. PCCs exposed to ECHO Pain (intervention group)
were compared with PCCs who did not participate in
ECHO Pain (comparison group).

Outcome Variables
Prescriptions analyzed included opioids and their MME, benzodiazepines, and the overlap in the co-prescription of opioids
and benzodiazepines. Opioids included codeine,
dihydrocodeine, belladonna-opium, fentanyl, hydrocodone,
hydromorphone, levorphanol, meperidine, morphine, methadone, oxycodone, tapentadol, and oxymorphone. Tramadol
was also included as a partial opioid. Benzodiazepines included diazepam, lorazepam, clonazepam, alprazolam,
temazepam, oxazepam, triazolam, midazolam, flurazepam,
estazolam, quazepam, clorazepate dipotassium, and chlordiazepoxide/clinidium.
Covariables of age, sex, and beneficiary category were
represented by the stratification used in the aggregation
of data.
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Fig. 1 Geographic distribution of army and navy ECHO pain hubs and spokes.

Timelines
Onset of participation in ECHO Pain was staggered over
4 years to accommodate training in the ECHO model for the
large number of Army and Navy hubs and spokes. Because
ECHO Pain lacked a single start date, the authors matched the
comparison groups with fiscal years to best analyze comparison and intervention groups. Demographics included
assigned sex, age, service, and beneficiary category (see
Aggregation in SOM).
A common timeline was determined based on yearly midpoints which are labeled as −1.5 − 0.5, + 0.5, and + 1.5 relative
to the starting time of ECHO Pain intervention (time = 0). For
the comparison group, fiscal year midpoints were used and the

first 2 years were labeled as − 1.5 and − 0.5 (see Definition of
Time Line in Supplemental Online Material (SOM)).

Analyses
Statistical significance was determined for rate changes over
time, both within and between groups, evaluated as slopes
using Repeated Measures (RM) Analysis of Covariance
(ANCOVA) weighted by the numbers of patients. Logtransformed data were used so that slopes represent relative
percent change. These percent changes are comparable.
Alternative analysis of primary outcomes used a propensity
scoring transformation with ECHO Pain as the target distribution to reduce selection bias in the baseline values. Alternative
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Fig. 2 Flow diagram: data collection and analysis.

analysis adjusted for sex, age, and beneficiary category as
covariables (see Propensity Scoring sections in SOM).
Outcome variables were analyzed as a time series of clinic
averages per patient. Opioid prescriptions were also analyzed
for percentages of opioid users, and opioid prescriptions per
opioid user, as these explanatory analyses are based on the
decomposition of rates given by the formula: opioid prescriptions per enrollee = (opioid scripts/opioid users) × (opioid
users/patients). MME rates and co-prescribed days of opioids
and benzodiazepines were analyzed similarly.

Institutional Review Board Approval
This study was approved by the UNMHSC Human Research
Protections Office (study ID #16-388) and the Defense Health
Agency (DHA) Institutional Review Board (CDO-16-2036
IRB #879675). A data sharing agreement (FP1032 DHA 171670) was signed by the DHA and UNMHSC to allow for data
to be shared between the two institutions.

RESULTS

Demographics and Baseline Rates
The comparison group had 1283 clinics and ECHO Pain had
99 clinics. Baseline demographics for ECHO Pain and comparison clinics for sex, age, service, and beneficiary status as
well as PCC participation level are given in Table 1.
Baseline demographics of adult beneficiaries included approximately 24,000 males (45.4%) and 29,000 females
(54.6%) whose PCCs participated in ECHO Pain. The comparison group included 721,000 males and 479,000 female
whose PCCs did not participate in ECHO Pain. Age distribution of adult beneficiaries for ECHO Pain was 18–24 years:
19.7%; 25–34 years: 30.6%; 35–44 years: 21.4%; and 45–
64 years: 28.3%, and the corresponding age distribution for
comparison group was 27.1%, 33.7%, 19.0%, and 20.2%.
Fifty-two percent of PCPs participated in four or more
TeleECHO clinics (see Table 1).
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Table 1 Baseline Demographics of Adult Study Patients 2013–2014a
Variables

Comparison
group

ECHO pain
group*

Patients seen per year
Sex
Female
Male
Age
18–24
25–34
35–44
45–64
Beneficiary category
Dependents of active duty
Retired
All others
Active duty and guard/reserve
Provider participation level in ECHO
Low (1–3 TeleECHO clinics)
Medium (4–19 TeleECHO
clinics)
High (> 20 TeleECHO clinics)

1,187,945

52,941

39.9%
60.1%

54.6%
45.4%

27.1%
33.7%
19.0%
20.2%

19.7%
30.6%
21.4%
28.3%

23.2%
10.1%
11.6%
55.1%

37.2%
14.3%
15.5%
33.0%

N/A
N/A

47.7%
32.1%

N/A

20.2%

a

The number of patients for non-ECHO Pain and ECHO Pain at
baseline (pooled 2013–2014) represent annualized totals on the flow
diagram (Fig. 2)
Comparison = adult patients enrolled with PCC who did not participate
in ECHO Pain; ECHO Pain = adult patients enrolled with PCC who
participated in ECHO Pain
*Variables sex, age, and beneficiary category differ significantly
between ECHO Pain and the Comparison groups (all P < 0.001)
possibly due to the large sample size indicated by patients seen

Opioid Prescriptions per Patient
While prescribed opioid rates declined in both comparison
clinics and ECHO Pain (both p < 0.001), the relative decline
was greater in clinics participating in ECHO Pain (Fig. 3a).
The average annual percent declines were 9.2% (p < 0.001)
from a baseline of 0.86 RX/patient/year in comparison clinics
and 23.0% (p < 0.001) from a baseline of 0.31 RX/patient/year
in ECHO Pain. The slopes differed between ECHO Pain and
comparison groups (p = 0.004, Table 2).

MME Dosages per Patient
While prescribed MME dosages declined in both comparison
clinics and ECHO Pain, the relative decline was greater in
clinics participating in ECHO Pain (Fig. 3b). The average
annual percent declines were 7.3% (p < 0.001) from a baseline
of 364 MME/patient/year in comparison clinics and 28.0%
(p = 0.002) from a baseline of 172 MME/patient/year in ECHO Pain. The slopes differed between ECHO Pain and comparison groups (p = 0.02, Table 2).

Co-prescribed Opioids and Benzodiazepines
per Patient
While days of co-prescribed opioids and benzodiazepines
declined in both comparison clinics and ECHO Pain, the
relative change was greater in clinics participating in ECHO
Pain (Fig. 3c). The average annual percent declines were 9.6%
(p < 0.001) from a baseline of 0.54 co-Rx/patients/year in
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comparison clinics and 68.9% (p < 0.001) from a baseline of
0.36 co-Rx/patient/year in ECHO Pain. The slopes differed
between ECHO Pain and comparison groups (p < 0.001).

Co-prescribed Opioids and Benzodiazepines
per Opioid User
While days of co-prescribed opioids and benzodiazepines per
opioid user declined in both comparison clinics and ECHO
Pain, the relative change was greater in clinics participating in
ECHO Pain (Fig. 3d). The average annual percent declines
were 1.3% (p = 0.41) from a baseline of 1.01 co-Rx/opioid
user/year in comparison clinics and 53.3% (p = 0.002) from a
baseline of 2.65 co-Rx/opioid user/year in ECHO Pain. The
slopes differed between ECHO Pain and comparison groups
(p < 0.001, Table 2).

Percent Opioid Users
While the percent of opioid users in their patient panels
declined in both comparison clinics and ECHO Pain, the
relative decline was greater in clinics participating in ECHO
Pain. The percent of opioid users in comparison clinics declined annually at 8.0% (p < 0.001) from an average annual
baseline of 53.6%. The percent of opioid users in ECHO Pain
declined annually at 20.2% (p < 0.001) from a baseline of
13.7%. The slopes differed between ECHO Pain and comparison groups (p < 0.001, Table 2).

Alternative Analysis
Since baseline values of outcome variables were higher for the
comparison group, a potential selection bias, an alternative
analysis was conducted to adjust for such a bias. Alternative
analyses for percent opioid users, average number of opioid
prescriptions per patient/year, and average MME/patients/year
used propensity scoring transformations. Resulting weights
were applied to the comparison group data, attempting to
reduce the selection bias present at baseline. Results were
adjusted for age, sex, and beneficiary status as covariables
(see SOM). Baseline bias was reduced, and since the alternative analysis results differ little from the original results, they
validate the original analysis (see Table 3 for primary outcome
variables).

DISCUSSION

Recent Centers for Disease Control and Prevention (CDC)
and Veteran’s Affairs (VA)/DoD guidelines recommend
safe opioid prescribing practices, especially focused on
moderate- and high-dose opioids (> 50 MME) and opioids
in combination with benzodiazepines.3, 32 Findings from
this study provide evidence that ECHO Pain may be used
as a successful tool for effectively teaching PCCs to apply
safe opioid prescribing practices.
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Fig. 3 Percent change for selected outcome measures.

Since the launch of ECHO Pain in 2012, many other interventions nationwide have been implemented to address the

opioid epidemic. These include the National Pain Strategy,
CDC Pain Management Guidelines, and the VA/DoD Opioid

Table 2 The Effects of ECHO Pain Clinician Participation on Prescribing of Opioids and Co-prescribing of Opioids and Benzodiazepines
Theme/variable

Comparison
baseline

Opioid analgesic prescriptions (Rx)
Avg. number of opioid
0.86
RX/patient/year
Avg. number of opioid
1.61
RX/opioid user/year
Percent opioid users
53.56
Morphine milligram equivalents (MME)
Avg. MME/patient/year
363.95
Avg. MME/opioid user/year
679.53
Percent opioid users
53.56
Co-prescribing opioids and benzodiazepines
Days of co-Rx/patient/year
0.54
Percent patients who are
3.26
co-Rx users
Days of co-RX/opioid user/year
1.01
Percent opioid users who
6.09
are co-Rx users

Interaction
P value

ECHO Pain
baseline

Comparison annual
change percentage,
P value

ECHO Pain annual
change percentage,
P value

0.31

− 9.2, P < 0.001

− 23.0, P < 0.001

0.004

2.27

− 0.6, P < 0.001

− 1.8, P = 0.36

0.41

13.69

− 8.0, P < 0.001

− 20.2, P < 0.001

< 0.001

171.57
1253.14
13.69

− 7.3, P < 0.001
+ 1.1, P = 0.30
− 8.0, P < 0.001

− 28.0, P = 0.002
− 6.2, P = 0.33
− 20.2, P < 0.001

0.02
0.32
< 0.001

0.36
1.22

− 9.6, P < 0.001
− 8.5, P < 0.001

− 68.9, P < 0.001
− 68.9, P < 0.001

< 0.001
< 0.001

2.65
8.92

− 1.3, P = 0.41
− 0.2, P = 0.82

− 53.3, P = 0.002
− 26.6, P = 0.002

< 0.001
< 0.001

Average annual percent change over the study period in comparison and ECHO Pain groups for several outcome measures concerning opioid use
(listed in the left column). Average annual change refers to regression slopes per year in the Repeated Measures (RM) ANCOVA analyses; negative
slopes indicate decline. Average baseline values (of the outcome variable listed in the corresponding row) are in the second and third columns for
comparison and ECHO Pain groups, respectively. The fourth and fifth columns contain the annual % changes (slopes) and P values testing whether
there was any change over time within a group. The final column contains the interaction P values testing whether the two slopes for comparison and
ECHO Pain groups differ and indicating whether the ECHO Pain intervention was effective
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Table 3 The Effects of ECHO Pain Participation on Prescribing: Results Adjusted for Selection Bias and for Sex, Age, Beneficiary Category
Covariables (Alternative Analysis)
Theme/variable

Comparison
baseline

Opioid analgesic prescriptions (Rx)
Avg. number of opioid
0.56
RX/patient/year
Percent opioid users
29.0
Morphine milligram equivalents (MME)
Avg. MME/patient/year
362
Percent opioid users
29.0

ECHO Pain
baseline

Comparison annual
change percentage,
P value

ECHO Pain annual
change percentage,
P value

Interaction
P value

0.31

− 6.4, P < 0.001

− 22.5, P < 0.001

< 0.001

13.5

− 8.0, P < 0.001

− 20.1, P < 0.001

< 0.001

176
13.5

− 10.6, P < 0.001
− 8.0, P < 0.001

− 27.5, P = 0.002
− 20.1, P < 0.001

< 0.001
< 0.001

Alternative analysis using a propensity scoring transformation with the ECHO distribution as target, i.e., ECHO Pain is unchanged but the comparison
group is weighted attempting to reduce the selection bias (see SOM). The addition of sex, age, beneficiary category to model adjusts for lack of balance
in Table 1. Importantly, annual change percentages are little affected validating the original analysis. These alternative analyses also do reduce baseline
bias

Guidelines, as well as the military sole provider program.1, 3,
These interventions may explain why both ECHO Pain
PCCs and the comparison group demonstrated declines in
opioids and co-prescription.
Clinicians who volunteered to participate in ECHO Pain
had lower rates of opioid prescribing and opioid/
benzodiazepine co-prescribing at baseline, with higher average baseline MME. We postulate that this difference reflects
clinicians who were early adopters of best practices for pain
management and who may have treated more challenging
chronic pain patients. Both ECHO Pain and comparison
groups had declines in opioid prescribing. ECHO Pain had
steeper declines than the comparison group even though it
started at a lower baseline. ECHO Pain PCCs may have had
more initial interest in learning about complex chronic pain
patients and developed self-efficacy in managing these patients by participating in ECHO Pain.26 Repeat exposure to
ECHO Pain deepens knowledge, skills, and confidence, and
may explain the robust reduction in opioid prescribing demonstrated in this study.35
The significant findings of this study provide evidence that
interventions such as ECHO Pain may contribute to reductions
in opioid prescribing and co-prescribing of benzodiazepines.
ECHO Pain incorporates case-based learning and didactics,
promotes increased PCC self-efficacy, knowledge development,
and increases social connectedness among participants.36, 37
Fifty-two percent of the PCCs exposed to ECHO Pain in
this study participated in ≥ four training sessions. This is
similar to the ECHO Pain dose-response seen in a recent large
Veterans administration SCAN-ECHO Pain analysis showing
improved quality of pain care.38 Future data analyses may
identify the necessary minimum exposure to ECHO Pain
which allows PCCs to acquire the knowledge and skills necessary for successful prescribing changes seen in this study.
Learning collaborative strategies posit that iterative educational processes are necessary to reduce variation in care and
promote practice change.39–41
Regardless of the educational platform (multi-point videoconferencing or live trainings), many key stakeholders agree
that clinician education in pain and opioid prescribing should
32–34

focus on providing more non-pharmacologic and non-opioid
pain management tools for PCCs while assuring that opioids are
prescribed safely when indicated.3, 35, 42 CME in pain management and safe opioid prescribing is associated with reductions in
opioid and benzodiazepine dispensing as well as reductions in
overdose mortality.43, 44 There is growing clinician and
policymaker support for mandated pain and addiction education.42, 45–47 Clinicians practicing in the military (DoD), the
Veterans Affairs, and the Indian Health Service (HIS) as well
as 23 states and the District of Columbia now have mandatory
CME requirements for pain and safe opioid prescribing.48

LIMITATIONS

This study has limitations related to data analysis and selection
bias. Most importantly, selection bias may explain the results
because of several naturally occurring factors. Because this
study could not randomize the assignment of clinicians and
patients into matched groups, the baseline demographics for
the comparison group are skewed towards male and active
duty patients. To the extent that these show up in baseline
outcome values, our alternative analysis with propensity scoring adjusts for this. In addition, PCCs volunteered to attend
ECHO Pain and, despite the fact that their patient panel
appeared to include highly complex chronic pain patients on
high doses of opioid analgesics, this clinician cohort may have
skewed the results.
The database is a de-identified, aggregated file from the
MDR and clinician ECHO Pain participation data provided by
the Army and Navy. Due to the aggregated nature of the data,
it was not possible to analyze the data down to the individual
clinician or patient level. Data was provided on individual
clinics with MTFs, but not on individual providers or patients.
Due to the aggregated nature of the data, the authors could
not specify the reasons opioids or benzodiazepines were used
in each patient. Additionally, it was not possible to (1) quantify
how each patient’s opioid MME dose may have changed or (2)
to address specific patient/level causes for the reductions in
opioid prescriptions, co-prescribing, and MME.
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CONCLUSION

The findings suggest that the ECHO model may be effective
both in reducing opioid-related prescription rates and in training PCCs. ECHO Pain reduces variation in care, promoting
case-based learning with short, pertinent, evidenced-based
didactics. This study suggests that clinician education in both
the federal and civilian sectors may have a substantial impact
on the opioid epidemic. Since ECHO Pain in this study represented only 5% of the beneficiary population, ECHO Pain
could be expanded to benefit a greater number of patients.
Additionally, future prospective clinical trials with chronic
pain and/or other common and complex conditions may provide information regarding the benefits of the ECHO model at
the patient level.
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